XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Unearned Common Stock held by the ESOP
Cumulative Effect, Period of Adoption, Adjusted Balance
Unearned Common Stock held by the ESOP
Retained Earnings
Cumulative effect of change in accounting principle
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Cumulative effect of change in accounting principle
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Balance at Dec. 31, 2022 $ 113 $ 113 $ 47,075 $ 47,075 $ (3,491) $ (3,491) $ (633) $ 95,991 $ 96,624 $ (32,189) $ (32,189) $ (633) $ 107,499 $ 108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                 798         798
Other comprehensive income (loss)                     2,221     2,221
ESOP shares committed to be allocated       (5)   54               49
Share-based compensation expense       150                   150
Balance at Mar. 31, 2023   113   47,220   (3,437)     96,789   (29,968)     110,717
Balance at Dec. 31, 2022 $ 113 113 $ 47,075 47,075 $ (3,491) (3,491) $ (633) $ 95,991 96,624 $ (32,189) (32,189) $ (633) $ 107,499 108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                           2,229
Other comprehensive income (loss)                           (1,273)
Balance at Jun. 30, 2023   111   45,976   (3,382)     98,220   (33,462)     107,463
Balance at Mar. 31, 2023   113   47,220   (3,437)     96,789   (29,968)     110,717
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                 1,431         1,431
Other comprehensive income (loss)                     (3,494)     (3,494)
ESOP shares committed to be allocated       (16)   55               39
Share-based compensation expense       150                   150
Repurchase of common stock   (2)   (1,378)                   (1,380)
Balance at Jun. 30, 2023   111   45,976   (3,382)     98,220   (33,462)     107,463
Balance at Dec. 31, 2023   111   45,959   (3,273)     100,386   (29,498)     113,685
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                 1,121         1,121
Other comprehensive income (loss)                     (580)     (580)
ESOP shares committed to be allocated       (8)   54               46
Balance at Mar. 31, 2024   111   45,951   (3,219)     101,507   (30,078)     114,272
Balance at Dec. 31, 2023   111   45,959   (3,273)     100,386   (29,498)     113,685
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                           2,096
Other comprehensive income (loss)                           326
Balance at Jun. 30, 2024   111   45,939   (3,164)     102,482   (29,172)     116,196
Balance at Mar. 31, 2024   111   45,951   (3,219)     101,507   (30,078)     114,272
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Income                 975         975
Other comprehensive income (loss)                     906     906
ESOP shares committed to be allocated       (12)   55               43
Balance at Jun. 30, 2024   $ 111   $ 45,939   $ (3,164)     $ 102,482   $ (29,172)     $ 116,196